Perinatal outcomes and congenital anomalies associated with letrozole and natural cycles in single fresh cleaved embryo transfers: A single-center, 10-year cohort study.
F S Rep
; 3(2): 138-144, 2022 Jun.
Article
em En
| MEDLINE
| ID: mdl-35789728
ABSTRACT
Objective:
To investigate and compare the safety of letrozole and natural cycles in fresh early embryo transfers.Design:
A retrospective cohort study.Setting:
A large fertility treatment center. Patients Women who underwent natural and letrozole cycles during fresh early embryo transfer at Kato Ladies Clinic between January 2008 and December 2017.Interventions:
None. Main Outcomemeasures:
Perinatal complications and congenital anomalies.Results:
No significant differences were observed in pregnancy complications, gestational age, birth weight, small for gestational age, large for gestational age, and congenital anomalies between the the women who underwent natural and letrozole cycles.Conclusions:
The perinatal outcomes and congenital anomaly rates associated with letrozole and natural cycles in fresh early embryo transfers were comparable. Therefore, our data support the safe use of letrozole in fresh early embryo transfers in assisted reproductive technology.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
F S Rep
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Japão